Verition Fund Management LLC - CEREVEL THERAPEUTICS HLDNG I ownership

CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 109 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.

Quarter-by-quarter ownership
Verition Fund Management LLC ownership history of CEREVEL THERAPEUTICS HLDNG I
ValueSharesWeighting
Q3 2022$550,550
-80.9%
38,914
-52.6%
0.01%
-82.9%
Q1 2022$2,876,000
+199.3%
82,135
+118.9%
0.04%
+288.9%
Q2 2021$961,000
-73.2%
37,528
-85.6%
0.01%
-77.5%
Q1 2021$3,590,000
+511.6%
261,504
+638.1%
0.04%
+700.0%
Q4 2020$587,00035,4300.01%
Other shareholders
CEREVEL THERAPEUTICS HLDNG I shareholders Q1 2022
NameSharesValueWeighting ↓
BAIN CAPITAL INVESTORS LLC 60,199,729$1,314,160,08442.08%
Perceptive Advisors 10,088,385$220,229,4457.35%
Finepoint Capital LP 563,345$12,297,8216.12%
Affinity Asset Advisors, LLC 685,061$14,954,8824.21%
Paradigm Biocapital Advisors LP 2,532,972$55,294,7793.75%
Logos Global Management LP 700,000$15,281,0002.04%
Artal Group S.A. 1,638,858$35,7761.53%
Rock Springs Capital Management LP 2,529,116$55,210,6021.48%
GREAT POINT PARTNERS LLC 215,000$4,693,4500.86%
Frazier Life Sciences Management, L.P. 393,000$8,579,1900.57%
View complete list of CEREVEL THERAPEUTICS HLDNG I shareholders